Research

Neurological Cancer Clinical Trials

The following clinical trials related to neurological cancers are available through the WPAHS. Please click on the link for more detailed information on the trial. Below each trial is the contact information at the WPAHS.

Study Title

A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Primary Glial Neoplasms of the Brain

Principal Investigator: Matthew R. Quigley, M.D.

Please also contact study coordinator for more information:

Diane Cantella Research Coordinator 412.359.3353 or dcantell@wpahs.org

Dorothy Packer Research Coordinator 412.359.6505 or dpacker@wpahs.org

Internal Reference: (RC#4764: Quigley MD)

Study Title

RTOG 0825: A Phase III Double-Blind Placebo-Controlled Trial of Conventional Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma

Principal Investigator: David Parda, M.D.

Please also contact study coordinator for more information:

Judy Negley, CCRP (Phone 412.359.4046)

Internal Reference: (RC4808/RTOG Parda)